First Horizon Advisors’s BioNTech BNTX Stock Holding History

First Horizon Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.93K	Sell	18 -143	-89%	-$14.4K	﹤0.01%	2045
2025 Q1	$14.7K	Sell	161 -168	-51%	-$18.8K	﹤0.01%	1449
2024 Q4	$37.5K	Sell	329 -56	-15%	-$6.39K	﹤0.01%	1071
2024 Q3	$45.7K	Sell	385 -36	-9%	-$3.31K	﹤0.01%	1026
2024 Q2	$33.8K	Buy	421 +47	+13%	+$4.3K	﹤0.01%	1090
2024 Q1	$34.5K	Buy	374 +18	+5%	+$1.73K	﹤0.01%	1126
2023 Q4	$37.6K	Buy	+356	New	+$35.9K	﹤0.01%	1070
2023 Q3	–	Sell	-4	Closed	-$431	–	2401
2023 Q2	$431	Sell	4 -4	-50%	-$450	﹤0.01%	2392
2023 Q1	$996	Hold	8	–	–	﹤0.01%	2265
2022 Q4	$1.2K	Hold	8	–	–	﹤0.01%	2192
2022 Q3	$1K	Hold	8	–	–	﹤0.01%	2090
2022 Q2	$1K	Buy	8 +5	+167%	+$764	﹤0.01%	2186
2022 Q1	$1K	Sell	3 -10	-77%	-$1.68K	﹤0.01%	1523
2021 Q4	$3K	Buy	13 +9	+225%	+$2.46K	﹤0.01%	1859
2021 Q3	$1K	Buy	+4	New	+$1.27K	﹤0.01%	2087

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Horizon Advisors's BNTX Position: Q2 2025 in Review

First Horizon Advisors reduced its BioNTech (BNTX) stake by 89% in Q2 2025, selling an estimated $14.4K and leaving 18 shares worth $1.93K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

First Horizon Advisors first reported a position in BNTX in Q3 2021 and has held it in 15 quarters since. The position peaked at $45.7K in Q3 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

First Horizon Advisors held 18 shares of BioNTech worth $1.93K as of Q2 2025.
First Horizon Advisors sold 143 BioNTech shares in Q2 2025, an estimated $14.4K.
BioNTech made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #2045 holding.
First Horizon Advisors first reported a position in BioNTech in Q3 2021 and has held it in 15 quarters since.
First Horizon Advisors's BioNTech position peaked at $45.7K in Q3 2024.
258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.